| 英文別名： |
Amikacin Sulphate;amikacin disulfate salt;4-amino-n-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide disulfate salt;Amikacin sulfate salt;Amikacin disulfate;Amikacin Sulfate;BAY-416651 sulfate;(2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-4-[(6-amino-6-;8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1);Amikacin disulphate salt;Amikin sulfate;4-Amino-N-[5-amino-2-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4-[6-(aminomethyl)-3,4,5-trihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-cyclohexyl]-2-hydroxy-butanamide disulfate;4-amino-N-[(2S,4S,5R)-5-amino-2-[(2S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamidesulfuric acid;CID 134129615;AMIKACIN DISULFATE;AMIKACIN DISULFATE SALT;AMIKACIN SULFATE;(s)-ysulfate(1:2)(salt);antibioticbb-k8sulfate;α-d-glucopyranosyl-(1-4))-n(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy;1-N-[L-(-)-γ-AMino-α-hydroxybutyryl]kanaMycin A Sulfate;BAY 41-6551 disulfate;O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine sulfate (1:2);Kaminax;CCG-270466;UNII-N6M33094FD;AMIKACIN SULFATE [VANDF];AMIKACIN SULFATE [GREEN BOOK];Amikacin bis(sulphate);Amikin;SCHEMBL1649432;Amikin (TN);NSC 755846;s3065;Amikacin for system suitability, European Pharmacopoeia (EP) Reference Standard;Amikacin sulfate, United States Pharmacopeia (USP) Reference Standard;(S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide bis(sulfate);AMIKACINI SULFAS [WHO-IP];Arikayce;EINECS 254-648-6;Q27105754;O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE SULFATE (1:2);AMIKACIN SULFATE [ORANGE BOOK];NN-K 8;Amikan;O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE SULPHATE (1:2);AMIKACIN SULFATE [EP IMPURITY];Kancin-Gap;Amitrex;AMIKACIN SULFATE [WHO-DD];D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-N(SUP 1)-(4-AMINO-2-HYDROXY-1-OXOBUTYL)-2-DEOXY-, (S)-, SULFATE (1:2) (SALT);D00865;Amikacin disulfate salt;39831-55-5;amikacin disulphate;Amikacin sulfate salt(1:2);Amikafur;Biodacyn;Amikacin (as sulfate);DTXSID601045247;Amikacin s... |
| 詳細(xì)描述： |
生化機(jī)理：二硫酸阿米卡星，又稱(chēng) BB-K 8，是一種氨基糖苷類(lèi)抗生素，對(duì)革蘭氏陰性菌具有活性。阿米卡星的活性與卡那霉素和慶大霉素相似。阿米卡星已被用于不同類(lèi)型的腎臟研究。我們提供二硫酸阿米卡星形式的氨基糖苷類(lèi)抗生素制劑?？敲顾?A 衍生物。與核糖體 RNA 結(jié)合。增加 p53 依賴(lài)性熒光素酶的激活。具有殺菌作用。在體內(nèi)具有活性。
應(yīng)用：An aminoglycoside antibiotic that is active against gram-negative bacteria
儲(chǔ)存溫度：-20°C儲(chǔ)存,充氬
運(yùn)輸條件：超低溫冰袋運(yùn)輸
作用類(lèi)型：抑制劑
作用機(jī)制：細(xì)菌 70S 核糖體抑制劑 |
滬公網(wǎng)安備31011402010658號(hào) 
